%0 Journal Article %T 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism. %A Ha J %A Park JH %A Kim KJ %A Kim JH %A Jung KY %A Lee J %A Choi JH %A Lee SH %A Hong N %A Lim JS %A Park BK %A Kim JH %A Jung KC %A Cho J %A Kim MK %A Chung CH %A %A %J Endocrinol Metab (Seoul) %V 38 %N 6 %D 2023 Dec 13 %M 37828708 %F 3.607 %R 10.3803/EnM.2023.1789 %X Primary aldosteronism (PA) is a common, yet underdiagnosed cause of secondary hypertension. It is characterized by an overproduction of aldosterone, leading to hypertension and/or hypokalemia. Despite affecting between 5.9% and 34% of patients with hypertension, PA is frequently missed due to a lack of clinical awareness and systematic screening, which can result in significant cardiovascular complications. To address this, medical societies have developed clinical practice guidelines to improve the management of hypertension and PA. The Korean Endocrine Society, drawing on a wealth of research, has formulated new guidelines for PA. A task force has been established to prepare PA guidelines, which encompass epidemiology, pathophysiology, clinical presentation, diagnosis, treatment, and follow-up care. The Korean clinical guidelines for PA aim to deliver an evidence-based protocol for PA diagnosis, treatment, and patient monitoring. These guidelines are anticipated to ease the burden of this potentially curable condition.